Human Investing’s Amedisys AMED Stock Holding History

Human Investing’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-363	Closed	-$67K	–	311
2020 Q1	$67K	Buy	+363	New	+$64.6K	0.03%	138

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Human Investing's AMED Position: Q2 2020 in Review

Human Investing sold out of Amedisys (AMED) in Q2 2020, closing a stake of 363 shares — an estimated $67K sold.

Human Investing first reported a position in AMED in Q1 2020 and held it in 1 quarter. The position peaked at $67K in Q1 2020. 354 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

Human Investing reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
Human Investing sold 363 Amedisys shares in Q2 2020, an estimated $67K.
Human Investing first reported a position in Amedisys in Q1 2020 and held it in 1 quarter.
Human Investing's Amedisys position peaked at $67K in Q1 2020.
354 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Human Investing's 13F filing for Q2 2020, filed 22 Jul 2020.